Literature DB >> 28299381

The renin-angiotensin system and prolylcarboxypeptidase.

Friedrich C Luft1.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28299381     DOI： 10.1007/s00109-017-1524-6

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN： 0946-2716            Impact factor:   4.599


× No keyword cloud information.
  8 in total

Review 1.  The kallikrein-kinin and the renin-angiotensin systems have a multilayered interaction.

Authors:  Alvin H Schmaier
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2003-07       Impact factor: 3.619

Review 2.  Salt Sensitivity of Blood Pressure: A Scientific Statement From the American Heart Association.

Authors:  Fernando Elijovich; Myron H Weinberger; Cheryl A M Anderson; Lawrence J Appel; Michael Bursztyn; Nancy R Cook; Richard A Dart; Christopher H Newton-Cheh; Frank M Sacks; Cheryl L Laffer
Journal:  Hypertension       Date:  2016-07-21       Impact factor: 10.190

Review 3.  The intrarenal renin-angiotensin system in hypertension.

Authors:  Robert M Carey
Journal:  Adv Chronic Kidney Dis       Date:  2015-05       Impact factor: 3.620

Review 4.  Salt-Sensitive Hypertension: Perspectives on Intrarenal Mechanisms.

Authors:  Dewan S A Majid; Minolfa C Prieto; Luis Gabriel Navar
Journal:  Curr Hypertens Rev       Date:  2015

5.  Murine prolylcarboxypeptidase depletion induces vascular dysfunction with hypertension and faster arterial thrombosis.

Authors:  Gregory N Adams; Gretchen A LaRusch; Evi Stavrou; Yihua Zhou; Marvin T Nieman; Gretta H Jacobs; Yingjie Cui; Yuan Lu; Mukesh K Jain; Fakhri Mahdi; Zia Shariat-Madar; Yoshio Okada; Louis G D'Alecy; Alvin H Schmaier
Journal:  Blood       Date:  2011-02-04       Impact factor: 22.113

6.  Prolylcarboxypeptidase deficiency is associated with increased blood pressure, glomerular lesions, and cardiac dysfunction independent of altered circulating and cardiac angiotensin II.

Authors:  Christoph Maier; Ines Schadock; Philipp K Haber; Jan Wysocki; Minghao Ye; Yashpal Kanwar; Christopher A Flask; Xin Yu; Brian D Hoit; Gregory N Adams; Alvin H Schmaier; Michael Bader; Daniel Batlle
Journal:  J Mol Med (Berl)       Date:  2017-02-03       Impact factor: 4.599

7.  Association of polymorphisms in prolylcarboxypeptidase and chymase genes with essential hypertension in the Chinese Han population.

Authors:  Yanrui Wu; Hongju Yang; Benguan Yang; Ke Yang; Chunjie Xiao
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2012-06-07       Impact factor: 1.636

Review 8.  Angiotensin (1-7) and Alamandine: Similarities and differences.

Authors:  Tawar Qaradakhi; Vasso Apostolopoulos; Anthony Zulli
Journal:  Pharmacol Res       Date:  2016-07-22       Impact factor: 7.658
  8 in total
  3 in total

1.  Genetic association study of prolylcarboxypeptidase polymorphisms with susceptibility to essential hypertension in the Yi minority of China: A case-control study based on an isolated population.

Authors:  Yanrui Wu; Hongju Yang; Chunjie Xiao
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2020 Apr-Jun       Impact factor: 1.636

2.  Haplotype-based association study between PRCP gene polymorphisms and essential hypertension in Hani minority group from a remote region of China.

Authors:  Yanrui Wu; Xingming Pan; Xiaoxiao Jin
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2020 Oct-Dec       Impact factor: 1.636

3.  Prolyl Carboxypeptidase Maintains Receptor Tyrosine Kinase Signaling and Is a Potential Therapeutic Target in Triple Negative Breast Cancer.

Authors:  Lei Duan; Sarah Calhoun; Ricardo E Perez; Virgilia Macias; Fatima Mir; Melissa R Pergande; Paolo Gattuso; Jeffrey A Borgia; Carl G Maki
Journal:  Cancers (Basel)       Date:  2022-01-31       Impact factor: 6.575
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.